Irvine, CA — Jan 28, 2020 — PacificDx will attend the Molecular Medicine Tri-Con Meeting in San Francisco California, March 1–4. Please visit our booth #600, or call us at 866.225.9195 or 949.812.6902 to set up a consultation at the show.
Everyone enjoys the aroma and taste of fresh bread from the oven, and of course, slathered with butter— but, if you are the ‘one’ in every 100 people who has been diagnosed with celiac disease or among the estimated 30% of the population who are genetically at risk for gluten intolerance, the downstream health effects […]
It’s been a long and difficult road for many who suffer from a disease they neither understand nor have been able to acquire a diagnosis. There is a significant crossover of signs and symptoms among gastrointestinal conditions and diseases that cause a burdensome diagnostic journey for the person trying to determine the cause of their […]
Irvine, CA — July 18, 2019 — PacificDx will attend the Association of Molecular Pathology (AMP) in Baltimore, Maryland November 7–9, 2019. Please visit our booth #2967, or call us at 866.225.9195 or 949.812.6902 to set up a consultation at the show.
Commercial assay for Tysabri (Natalizumab) developed to enable physicians to make data driven decisions on how to optimize the infusion schedule for their multiple sclerosis patients. SAN DIEGO, Calif. (PRWEB) August 30, 2018 — Abreos Biosciences, a leader in the precision dosing of biological therapeutics, is pleased to announce a collaboration with ResearchDx, a recognized […]
Irvine, CA — Oct 1, 2018 — PacificDx will be at the Association of Molecular Pathology (AMP) in San Antonio, Texas, November 1–3, 2018. Please visit us at the ResearchDx booth #602, or call us at 866.225.9195 or 949.812.6901 to set up a consultation at the show.